0.8070USD+3.63%Mkt Cap: 10.34M USDP/E: —Last update: 2026-05-22
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL l…
Industry Peers
Drug Manufacturers - Specialty & Generic153.28BSEKP/E 169.8
56.23BTRYP/E 26.9
55.91BEURP/E 22.1
33.39BPLNP/E 21.7
13.24BSEKP/E 39.8
13.20BEURP/E 30.1
12.83BTRY—
10.85BUSD—
loading…
Indicators:|
Key Statistics
Company
Market Cap10.34M USD
Enterprise Value10.50M USD
Revenue (TTM)43.20M USD
Gross Profit30.74M USD
Net Income (TTM)-10.54M USD
Revenue/Share3.973 USD
Last Price0.8070 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees84
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-3.39
PEG—
EV/EBITDA-0.99
EV/Revenue0.24
P/S0.23
P/B1.50
EPS (TTM)-0.98
EPS (Forward)-0.23
52W Range
0.536041% of range1.190
52W High1.190 USD
52W Low0.5360 USD
Profitability
Gross Margin73.71%
Oper. Margin-38.95%
EBITDA Margin-24.45%
Profit Margin-25.26%
ROE-100.53%
ROA-36.89%
Growth
Revenue Growth17.40%
Earnings Growth—
Cash Flow & Leverage
Operating CF-13.36M USD
CapEx (TTM)2.00K USD
FCF Margin3.18%
FCF Yield13.29%
Net Debt1.40M USD
Net Debt/EBITDA-0.13
Balance Sheet
Debt/Equity0.59
Current Ratio1.21
Quick Ratio0.93
Book Value/Sh0.5200 USD
Cash/Share0.5410 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:20
Split DateJul 5, 2023
Analyst Consensus
Rating1.0 (Strong Buy)
Target (Mean)5.875 USD
Target Range2.750 USD – 9.000 USD
# Analysts2
Ownership
Shares Out.12.80M
Float8.08M
Insiders12.84%
Institutions21.97%
Short Interest
Short Ratio0.6d
Short % Float0.66%
Short % Out.0.64%
Shares Short76.36K
Short (prev mo.)295.93K
Technical
SMA 500.9740 (-17.1%)
SMA 2000.9126 (-11.6%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)222.83K
Avg Vol (10d)398.26K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—